A Phase I, Multicenter, Open-label, Single-dose, Dose Ra

Project: Research project

Project Details

Description

A Phase I, Multicenter, Open-label, Single-dose, Dose Ranging Study to Assess the Safety and Tolerability of SB-318, a rAAV2/6-based Gene Transfer in Subjects with Mucopolysaccharidosis I (MPS)
StatusFinished
Effective start/end date4/18/174/30/20

Funding

  • Sangamo Therapeutics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.